Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-01-07 @ 11:59 AM
Study NCT ID:
NCT01356160
Status:
COMPLETED
Last Update Posted:
2014-02-03
First Post:
2011-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-02
First Submit QC Date:
None
Study First Post Date:
2011-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-12-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-01-02
Last Update Post Date:
2014-02-03
Last Update Post Date Type:
ESTIMATED